Market Overview:
The global triamcinolone drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for generic drugs. In addition, the increasing use of triamcinolone drug in various applications such as hospitals, drugstores, and others is also contributing to the growth of this market. However, stringent regulatory norms and high cost associated with R&D are some of the major factors restraining the growth of this market. On the basis of type, cream segment dominates the global triamcinolone drug market owing to its high usage rates across various applications such as hospitals and others segments.
Product Definition:
A synthetic corticosteroid drug used to treat various medical conditions including Crohn's disease, asthma, and rheumatoid arthritis. Triamcinolone is a prescription medication that comes in the form of a cream, ointment, lotion, or injection. It is important for treating inflammation and reducing pain.
Cream:
Cream is a topical corticosteroid used for the treatment of skin-related conditions such as eczema. It works by reducing inflammation and itching. Corticosteroids are among the most commonly prescribed medications to treat itchy skin conditions like atopic dermatitis, psoriasis, sebostasis etc.
Injection:
Injection is a form of medication used to treat inflammation, pain, and swelling. It works by reducing the amount of fluid in the joint spaces or synovial fluid. Triamcinolone acetonide injection is used for treating acute gouty arthritis; it reduces pain and attacks the cause of the disease (inflammatory process).
Application Insights:
The others segment held the largest share of over 70.0% in 2017. The major application of this drug is found outside hospitals and clinics, such as airports, sports arenas and theaters among others places where skin infections are common. This cream is used for treating various skin conditions including eczema, psoriasis, dermatitis and ¢â‚¬Å“dry¢â‚¬ eczema patches on the body caused due to weather changes or change in season. It also helps prevent further damage to already damaged skin cells by enhancing collagen production which reduces wrinkles caused due to chronic sun exposure or wind burn injury on exposed areas of skin that causes severe itching sensation for few days after injury occurs.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing incidence of skin disorders, rising adoption of cosmetic products, and high healthcare expenditure in this region. In addition, growing number of dermatology clinics and hospitals are also contributing towards market growth in North America.
Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising disposable income resulting into increased demand for pharmaceutical products among individuals as well as corporate entities along with government initiatives for improving public health system & infrastructure especially in developing countries such as India & China etc.
Moreover, favorable regulatory framework that allows easy access.
Growth Factors:
- Increasing incidence of skin diseases: The global triamcinolone drug market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing incidence of skin diseases such as psoriasis, eczema, and dermatitis.
- Rising awareness about available treatment options: There is an increasing awareness among people about the available treatment options for various skin diseases. This is expected to drive the demand for triamcinolone drugs in the coming years.
- Growing number of product approvals: The number of product approvals for triamcinolone drugs has been growing in recent years, which is likely to boost market growth during the forecast period. For instance, In November 2017, AstraZeneca received approval from FDA for its new drug candidate – Fasenra – a subcutaneous injection formulation of benralizumab (anti-IL-5 receptor alpha monoclonal antibody) for treating severe eosinophilic asthma in adults aged 18 years and older . This will provide an impetus to market growth over the next few years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Triamcinolone Drug Market Research Report
By Type
Cream, Injection, Inhalation, Others
By Application
Hospitals, Drugstores, Others
By Companies
Sanofi, Bristol-Myers Squibb, J&J, Mylan, GSK, Cadila, Abbott, Novartis, China Resources Sanjiu, Teligent, Sun Pharmaceutical, Glenmark, Teijin Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Triamcinolone Drug Market Report Segments:
The global Triamcinolone Drug market is segmented on the basis of:
Types
Cream, Injection, Inhalation, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Drugstores, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Bristol-Myers Squibb
- J&J
- Mylan
- GSK
- Cadila
- Abbott
- Novartis
- China Resources Sanjiu
- Teligent
- Sun Pharmaceutical
- Glenmark
- Teijin Pharma
Highlights of The Triamcinolone Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cream
- Injection
- Inhalation
- Others
- By Application:
- Hospitals
- Drugstores
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Triamcinolone Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Triamcinolone is a corticosteroid medication that is used to treat various types of inflammation, including asthma, hay fever, and other allergies. It works by reducing the swelling and inflammation caused by these conditions. Triamcinolone can also be used to reduce the symptoms of other medical conditions, such as Crohn's disease or rheumatoid arthritis.
Some of the key players operating in the triamcinolone drug market are Sanofi, Bristol-Myers Squibb, J&J, Mylan, GSK, Cadila, Abbott, Novartis, China Resources Sanjiu, Teligent, Sun Pharmaceutical, Glenmark, Teijin Pharma.
The triamcinolone drug market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Triamcinolone Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Triamcinolone Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Triamcinolone Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Triamcinolone Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Triamcinolone Drug Market Size & Forecast, 2020-2028
4.5.1 Triamcinolone Drug Market Size and Y-o-Y Growth
4.5.2 Triamcinolone Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cream
5.2.2 Injection
5.2.3 Inhalation
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Drugstores
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Triamcinolone Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Triamcinolone Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cream
9.6.2 Injection
9.6.3 Inhalation
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Drugstores
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cream
10.6.2 Injection
10.6.3 Inhalation
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Drugstores
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cream
11.6.2 Injection
11.6.3 Inhalation
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Drugstores
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cream
12.6.2 Injection
12.6.3 Inhalation
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Drugstores
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cream
13.6.2 Injection
13.6.3 Inhalation
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Drugstores
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Triamcinolone Drug Market: Competitive Dashboard
14.2 Global Triamcinolone Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Bristol-Myers Squibb
14.3.3 J&J
14.3.4 Mylan
14.3.5 GSK
14.3.6 Cadila
14.3.7 Abbott
14.3.8 Novartis
14.3.9 China Resources Sanjiu
14.3.10 Teligent
14.3.11 Sun Pharmaceutical
14.3.12 Glenmark
14.3.13 Teijin Pharma
